Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Borst GR et al. - The authors derived a significant dose–response relationship between the risk of RP and the MLD for SBRT from the clinical data. This relation was not significantly different from the dose–response relation for CFRT, although statistical analysis was hampered by the low number of patients in the high dose range.



Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address